TJ Madsen is among the founding members of the New Herald Tribune and chairs the editorial board. He worked for national syndicated newspapers in Newark, Philadelphia, and Baltimore before moving to the midwest.
April 30 , 2024
Washington, D.C. — The U.S. Drug Enforcement Administration (DEA) has announced the reclassification of both marijuana and Ozempic, a medication used to treat type 2 diabetes. The decision comes after legendary singer and actress Barbara Streisand publicly advocated for changes in drug policy and medical treatment.
Barbara Streisand, known for her powerful voice and activism, recently spoke out about the need for more compassionate drug policies. In a series of tweets, she highlighted the impact of outdated regulations on patients’ lives and urged federal agencies to reconsider their stance on marijuana and other medications.
Marijuana, a plant with a long history of medicinal use, has been classified as a Schedule I drug for decades. This classification has hindered research, limited patient access, and perpetuated stigma. However, the DEA’s decision to reclassify it signals a shift toward evidence-based policy. Under the new classification, marijuana will move from Schedule I to Schedule II, acknowledging its potential medical benefits while maintaining regulatory control.
Ozempic (generic name semaglutide) is a once-weekly injectable medication used to improve blood sugar control in adults with type 2 diabetes. Previously classified as a Schedule IV drug, it will now be reclassified as Schedule III. This change reflects growing evidence of its safety and efficacy, as well as the need to streamline access for patients managing diabetes.
Advocates for drug policy reform and patients alike have welcomed these developments. However, some critics argue that the reclassification doesn’t go far enough. They emphasize the importance of further research and education to ensure responsible use of both substances.
The DEA’s decision triggers a public-comment period during which experts, stakeholders, and concerned citizens can provide input. Additionally, federal agencies will collaborate to update guidelines for medical professionals, patients, and law enforcement. The goal is to strike a balance between patient access and public safety.
Barbara Streisand’s influence has played a pivotal role in pushing for these changes. As the nation grapples with evolving attitudes toward drug policy and healthcare, the reclassification of marijuana and Ozempic represents a step toward a more compassionate and informed approach.
Copyright © 2026. All rights reserved.